Comparison of 111In-labeled somatostatin analogues for tumor scintigraphy and radionuclide therapy

Cancer Research

Volumn 58, Issue 3, 1998, Pages 437-441

  De Jong, Marion ^a   Breeman, Wout A P ^a   Bakker, Willem H ^a   Kooij, Peter P M ^a   Bernard, Bert F ^a   Hofland, Leo J ^a   Visser, Theo J ^a   Srinivasan, Ananth ^b   Schmidt, Michelle A ^b   Erion, Jack L ^b   Bugaj, Joseph E ^b   Mäcke, Helmut R ^c   Krenning, Eric P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MALLINCKRODT PHARMACEUTICALS   (United States)

^c Kantonspital Basel ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INDIUM 111; OCTEROTIDE[1 DEXTRO TYROSINE] PENTETATE INDIUM IN 111; OCTREOTIDE PENTETATE INDIUM IN 111; OCTREOTIDE[3 TYROSINE]; OCTREOTIDE[3 TYROSINE] PENTETATE INDIUM IN 111; PENTETATE INDIUM IN 111; PENTETIC ACID DERIVATIVE; SOMATOSTATIN DERIVATIVE; TETRAAZACYCLODODECANETETRAACETATE INDIUM IN 111; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; DRUG DERIVATIVE; INDIUM; INDIUM 111 OCTREOTIDE; INDIUM-111-OCTREOTIDE; OCTREOTIDE; SOMATOSTATIN RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; DRUG UPTAKE; INTERNALIZATION; ISOTOPE LABELING; NONHUMAN; PANCREAS TUMOR; PRIORITY JOURNAL; RADIOACTIVITY; RAT; TUMOR SCINTISCANNING; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; HUMAN; HYPOPHYSIS TUMOR; LEWIS RAT; MALE; METABOLISM; MOUSE; NEOPLASM; PATHOLOGY; SCINTISCANNING; TISSUE DISTRIBUTION; WISTAR RAT;

ANIMALS; HUMANS; INDIUM RADIOISOTOPES; MALE; MICE; NEOPLASMS; OCTREOTIDE; PANCREATIC NEOPLASMS; PITUITARY NEOPLASMS; RATS; RATS, INBRED LEW; RATS, WISTAR; RECEPTORS, SOMATOSTATIN; TISSUE DISTRIBUTION;

EID: 0031987328     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Krenning, E. P., Bakker, W. H., Breeman, W. A. P., Koper, J. W., Kooij, P. P. M., Ausema, L., Laméris, J. S., Reubi, J. C., and Lamberts, S. W. J. Localisation of endocrine-related tumors with radioiodinated analogue of somatostatin. Lancet, i: 242-244, 1989.
2. Patel, Y. C., and Wheatley, T. In vivo and in vitro plasma disappearance and metabolism of somatostatin-28 and somatostatin-14 in the rat. Endocrinology, 112: 220-225, 1983.
3. Pless, J., Bauer, W., Briner, U., Doepfner, W., Marbach, P., Maurer, R., Petcher, T. J., Reubi, J. C., and Vonderscher, J. Chemistry and pharmacology of SMS 201-995, a long-acting analogue of somatostatin. Scand. J. Gastroenterol., 21: 54-64, 1986.
4. Bakker, W. H., Krenning, E. P., Breeman, W. A. P., Koper, J. W., Kooij, P. P. M., Reubi, J. C., Klijn, J. G., Visser, T. J., Docter, R., and Lamberts, S. W. J. Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity and in vivo application in animals. J. Nucl. Med., 31: 1501-1509, 1990.
5. Bakker, W. H., Krenning, E. P., Breeman, W. A. P., Kooij, P. P. M., Reubi, J. C., Koper, J. W., De Jong, M., Laméris, J. S., Visser, T. J., and Lamberts, S. W. J. In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism, and binding to somatostatin receptor-positive tumors in man. J. Nucl. Med., 32: 1184-1189, 1991.
6. 3]-octreotide. J. Nucl. Med., 33: 652-658, 1992.
7. 3]-oct-reotide: the Rotterdam experience with more than 1000 patients. Eur. J. Nucl. Med., 20: 716-731, 1993.
8. Krenning, E. P., Kooij, P. P. M., Pauwels, S., Breeman, W. A. P., Postema, P. T. E., De Herder, W. W., Valkema, R., and Kwekkeboom, D. J. Somatostatin receptor scintigraphy and radionuclide therapy. Digestion, 57: 57-61, 1996.
9. 3]octreotide, a promising somatostatin analogue for radionuclide therapy. Eur. J. Nucl. Med., 24: 368-371, 1997.
10. 3]octreotide, as carriers for octreotide receptor-targeted scintigraphy and radionuclide therapy. Int. J. Cancer, in press, 1998.
11. Otte, A., Jermann, E., Béhé, M., Goetze, M., Bucher, H. C., Roser, H. W., Heppeler, A., Müller-Brand, J., and Mäcke, H. R. DOTATOC: a powerful new tool for receptor-mediated radionuclide-therapy. Eur. J. Nucl. Med., 24: 792-795, 1997.
12. 1]-octreoude, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation. Life Sci., 49: 1583-1591, 1991.
13. Hofland, L. J., Van Koetsveld, P. M., Wouters, N., Waaijers, M., Reubi, J. C., and Lamberts, S. W. J. Dissociation of antiproliferative and antihormonal effect of the somatostatin analogue octreotide on 7315b pituitary tumor cells. Endocrinology, 131: 571-577, 1992.
14. 3]octreotide, by mouse and human pituitary tumour cells. Endocrinology, 136: 3698-3706, 1995.
15. 1octreotide. J. Nucl. Med., 37: 2002-2006, 1996.
16. Hammond, P. J., Wade, A. F., Gwilliam, M. E., Peters, A. M., Myers, M. J., Gilbey, S. G., Bloom, S. R., and Calam, J. Amino acid infusion blocks renal tubular uptake of an indium-labelled somatostatin analogue. Br. J. Cancer, 67: 1437-1439, 1993.
17. Pimm, M. V., and Gribben, S. J. Prevention of renal tubule re-absorption of radiometal (indium-111) labelled Fab fragment of a monoclonal antibody in mice by systemic administration of lysine. Eur. J. Nucl. Med., 21: 663-665, 1994.
18. Behr, T. M., Sharkey, R. M., Juweid, M. E., Blumenthal, R. D., Dunn, R. M., Griffith, G. L., Bair, H-J., Wolf, F. G., Becker, W. S., and Goldenberg, D. M. Reduction of the renal uptake of radiolabelled monoclonal antibody fragments by cationic amino acids and their derivatives. Cancer Res., 55: 3825-3834, 1995.
19. 111In-DTPA-octreotide in vivo. J. Nucl. Med., 37: 1388-1392, 1996.